People

Geoff Leonard focuses his practice on the representation of technology companies, including life science companies. Geoff is a partner in our Corporate Governance and Mergers & Acquisitions practices, with considerable experience in the areas of securities and corporate finance, including equity and debt offerings, mergers and acquisitions, venture capital, private equity and strategic alliances.

Geoff counsels technology companies, particularly in life sciences, concerning securities and corporate finance matters, and handles equity and debt offerings, mergers and acquisitions, venture capital, private equity and strategic alliances. He also advises public companies on securities matters, as well as in ongoing Securities and Exchange Commission reporting matters.

In addition, Geoff regularly serves venture-backed companies as principal outside counsel. He has been counsel to numerous companies at every life-cycle stage, from incorporation through venture funding and final exit, as well as to the investors that finance these companies.

Geoff was recognized by Legal 500 in 2016 in Healthcare: Life Sciences and in two M&A categories—Middle Market and Venture Capital and Emerging Companies. He also was cited by Corporate INTL as Technology Sector M&A Attorney of the Year in California for 2014, and by Finance Monthly as a 2012 Deal Maker of the Year.

Full Bio

Credentials

J.D., Georgetown University Law Center, cum laude

B.A. History, Trinity College

California

New York

Healthcare: Life Sciences


Legal 500, 2016

M&A: Middle Market


Legal 500, 2016

M&A: Venture Capital and Emerging Companies


Legal 500, 2016

Technology Sector M&A Attorney of the Year, California


Corporate INTL, 2014

2012 Deal Maker of the Year


Finance Monthly

Icon close

Close

Recognition

Healthcare: Life Sciences


Legal 500, 2016

M&A: Middle Market


Legal 500, 2016

M&A: Venture Capital and Emerging Companies


Legal 500, 2016

Technology Sector M&A Attorney of the Year, California


Corporate INTL, 2014

2012 Deal Maker of the Year


Finance Monthly

Matters

Represented Claret Medical in its sale to Boston Scientific Corporation for $270 million.

Represented Apama Medical from inception through its subsequent sale to Boston Scientific Corporation for up to $300 million.

Represented C2 Therapeutics from inception through its subsequent sale to Hoya Corporation.

See more
Icon close

Close

Matters

Represented Claret Medical in its sale to Boston Scientific Corporation for $270 million.

Represented Apama Medical from inception through its subsequent sale to Boston Scientific Corporation for up to $300 million.

Represented C2 Therapeutics from inception through its subsequent sale to Hoya Corporation.

Represented Vector Laboratories in its sale to the private equity firm GTCR.

Represented Lightstone Ventures as joint investors along with New Enterprise Associates and Medtronic in a new company, FIRE1, launched by The Foundry, a premier medical device incubator.

Represented Access Closure from inception through its subsequent sale to Cardinal Health for $320 million.

Represented Sadra Medical from inception through its venture financings and in its subsequent sale to Boston Scientific for up to $450 million.

Represented Nestle S.A. in its joint venture with The Coca-Cola Company for the worldwide marketing and sale of Nestea.

Represented TPG Opportunity Partners and Clarus Ventures in their acquisition and subsequent sale of a royalty interest of Gilead Sciences.

Represented Skire, Inc. in its sale to Oracle Corp.

Matters

Represented Claret Medical in its sale to Boston Scientific Corporation for $270 million.

Represented Apama Medical from inception through its subsequent sale to Boston Scientific Corporation for up to $300 million.

Represented C2 Therapeutics from inception through its subsequent sale to Hoya Corporation.

See more
Icon close

Close

Matters

Represented Claret Medical in its sale to Boston Scientific Corporation for $270 million.

Represented Apama Medical from inception through its subsequent sale to Boston Scientific Corporation for up to $300 million.

Represented C2 Therapeutics from inception through its subsequent sale to Hoya Corporation.

Represented Vector Laboratories in its sale to the private equity firm GTCR.

Represented Lightstone Ventures as joint investors along with New Enterprise Associates and Medtronic in a new company, FIRE1, launched by The Foundry, a premier medical device incubator.

Represented Access Closure from inception through its subsequent sale to Cardinal Health for $320 million.

Represented Sadra Medical from inception through its venture financings and in its subsequent sale to Boston Scientific for up to $450 million.

Represented Nestle S.A. in its joint venture with The Coca-Cola Company for the worldwide marketing and sale of Nestea.

Represented TPG Opportunity Partners and Clarus Ventures in their acquisition and subsequent sale of a royalty interest of Gilead Sciences.

Represented Skire, Inc. in its sale to Oracle Corp.

Credentials

J.D., Georgetown University Law Center, cum laude

B.A. History, Trinity College

California

New York

Healthcare: Life Sciences


Legal 500, 2016

M&A: Middle Market


Legal 500, 2016

M&A: Venture Capital and Emerging Companies


Legal 500, 2016

Technology Sector M&A Attorney of the Year, California


Corporate INTL, 2014

2012 Deal Maker of the Year


Finance Monthly

Icon close

Close

Recognition

Healthcare: Life Sciences


Legal 500, 2016

M&A: Middle Market


Legal 500, 2016

M&A: Venture Capital and Emerging Companies


Legal 500, 2016

Technology Sector M&A Attorney of the Year, California


Corporate INTL, 2014

2012 Deal Maker of the Year


Finance Monthly